HF Risk | CBR Polymorphism | DOX | EPI | DNR | IDA | ||||
---|---|---|---|---|---|---|---|---|---|
Experimental | Clinical | Experimental | Clinical | Experimental | Clinical | Experimental | Clinical | ||
5% | − | 380 | 400 | 920 | 900 | 360 | 600–800 | 180 | 290 |
+ | 330 | — | 840 | — | 190 | — | 105 | — | |
(−13%) | (−9%) | (−47%) | (−42%) | ||||||
1%–2% | − | 220–280 | 300–340 | 580–720 | 600–700 | 170–270 | — | 100–130 | — |
+ | 180–230 | — | 510–650 | — | 120–160 | — | 65–80 | — | |
(−18%) (−18%) | (−12%) (−10%) | (−29%) (−41%) | (−35%) (−38%) |